Letter: Anticoagulant control, immunosuppression, and glomerulonephritis.
D000925:Anticoagulants / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D005921:Glomerulonephritis / Q000097:blood / Q000188:drug therapy*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007616:Kaolin / Q000097:blood; D010714:Phosphatidylethanolamines / Q000097:blood; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D010714:Phosphatidylethanolamines; D007616:Kaolin; D014859:Warfarin; D006493:Heparin